These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15956013

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR.
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Is aspirin still the antiplatelet drug of choice for patients with peripheral arterial disease?
    Matsagas MI, Jagroop IA, Mikhailidis DP, Geroulakos G.
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):281-2. PubMed ID: 12624855
    [No Abstract] [Full Text] [Related]

  • 25. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
    Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W, Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators.
    Stroke; 2004 Feb; 35(2):528-32. PubMed ID: 14739421
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comment: mortality benefit of no-load clopidogrel in COMMIT: not a surprise.
    Serebruany VL.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):99-100. PubMed ID: 16703225
    [No Abstract] [Full Text] [Related]

  • 28. Aspirin versus clopidogrel: the wrong question?
    Born GV, Collins R.
    Lancet; 1997 Mar 15; 349(9054):806-7. PubMed ID: 9074601
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
    O'Donoghue M, Wiviott SD.
    Circulation; 2006 Nov 28; 114(22):e600-6. PubMed ID: 17130347
    [No Abstract] [Full Text] [Related]

  • 36. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008 Nov 28; 19(3):165. PubMed ID: 18568182
    [No Abstract] [Full Text] [Related]

  • 37. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators.
    Eur Heart J; 2000 Dec 28; 21(24):2033-41. PubMed ID: 11102254
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
    ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.
    N Engl J Med; 2009 May 14; 360(20):2066-78. PubMed ID: 19336502
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.